Literature DB >> 31696467

MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3.

Q-L Zhu1, D-M Zhan, Y-K Chong, L Ding, Y-G Yang.   

Abstract

OBJECTIVE: Increasing evidence indicated that microRNAs (miRNAs) are crucial regulators for cancer development. Bladder cancer (BCa) is a major threat to human health. The aim of this study was to analyze the roles of miR-652-3p in BCa, and to explore the associated mechanisms.
MATERIALS AND METHODS: MiR-652-3p expression in BCa cell lines was explored using Real Time-quantitative Polymerase Chain Reaction (RT-qPCR) method. MiR-652-3p expression level in BCa tissues was explored at StarBase. Cell Counting Kit-8 (CCK-8) assay, wound-healing assay, and transwell invasion assay were conducted to investigate the biological roles of miR-652-3p. The underlying mechanisms of miR-652-3p in NSCLC were investigated using luciferase activity reporter assay and rescue experiments.
RESULTS: We showed that miR-652-3p expression level was upregulated in both BCa tissues and cell lines. The knockdown of miR-652-3p significantly inhibited BCa cell proliferation, migration, and invasion in vitro. Moreover, we showed that potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 (KCNN3) was a functional target for miR-652-3p. Besides, the expression of KCNN3 in BCa tissues was negatively correlated with miR-652-3p.
CONCLUSIONS: Collectively, these results showed that miR-652-3p could promote BCa cell proliferation, migration, and invasion via directly regulating KCNN3, which may provide a novel therapeutic target for BCa treatment.

Entities:  

Year:  2019        PMID: 31696467     DOI: 10.26355/eurrev_201910_19275

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels.

Authors:  Xiaozeng Lin; Yan Gu; Yingying Su; Ying Dong; Pierre Major; Anil Kapoor; Damu Tang
Journal:  Cancers (Basel)       Date:  2022-06-05       Impact factor: 6.575

Review 2.  MicroRNAs: Important Regulatory Molecules in Acute Lung Injury/Acute Respiratory Distress Syndrome.

Authors:  Qianying Lu; Sifan Yu; Xiangyan Meng; Mingyu Shi; Siyu Huang; Junfeng Li; Jianfeng Zhang; Yangfan Liang; Mengjun Ji; Yanmei Zhao; Haojun Fan
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

Review 3.  Targets and regulation of microRNA-652-3p in homoeostasis and disease.

Authors:  Maxwell T Stevens; Bernadette M Saunders
Journal:  J Mol Med (Berl)       Date:  2021-03-12       Impact factor: 4.599

4.  Effective Prediction of Prostate Cancer Recurrence through the IQGAP1 Network.

Authors:  Yan Gu; Xiaozeng Lin; Anil Kapoor; Taosha Li; Pierre Major; Damu Tang
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

Review 5.  microRNAs Mediated Regulation of the Ribosomal Proteins and its Consequences on the Global Translation of Proteins.

Authors:  Abu Musa Md Talimur Reza; Yu-Guo Yuan
Journal:  Cells       Date:  2021-01-08       Impact factor: 6.600

6.  MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.

Authors:  Srinivasulu Yerukala Sathipati; Ming-Ju Tsai; Sanjay K Shukla; Shinn-Ying Ho; Yi Liu; Afshin Beheshti
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

7.  Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways.

Authors:  Michał Janowski; Zofia Ulańczyk; Karolina Łuczkowska; Anna Sobuś; Dorota Rogińska; Ewa Pius-Sadowska; Michał Gniot; Krzysztof Kozłowski; Krzysztof Lewandowski; Grzegorz Helbig; Bogusław Machaliński; Edyta Paczkowska
Journal:  Onco Targets Ther       Date:  2022-10-10       Impact factor: 4.345

8.  Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.

Authors:  Xiaobin Chi; Yi Jiang; Yongbiao Chen; Lizhi Lv; Jianwei Chen; Fang Yang; Xiaojin Zhang; Fan Pan; Qiucheng Cai
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.